Our Pricing

Orlistat vs Ozempic: Private Prescription UK

Published on: June 03, 2026

Choosing between orlistat vs ozempic uk prescription options can feel overwhelming when you're ready to start your weight loss journey. At Cured Pharmacy, our UK-registered clinical team helps patients understand the fundamental differences between oral lipase inhibitors like Orlistat and injectable GLP-1 receptor agonists like Ozempic (semaglutide), ensuring you receive the treatment best suited to your medical profile and lifestyle.

How Orlistat and Ozempic Work Differently

Orlistat and Ozempic operate through entirely different mechanisms, which explains their contrasting efficacy profiles and side effect patterns. Orlistat (marketed as Xenical or Alli) is a lipase inhibitor that blocks approximately 30% of dietary fat absorption in your digestive system [1]. The unabsorbed fat passes through your bowel, which means Orlistat only works when you consume fat-containing meals and has no systemic hormonal effects.

Ozempic contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone involved in appetite regulation and glucose metabolism [2]. Unlike Orlistat's localised digestive action, semaglutide works systemically—slowing gastric emptying, reducing appetite signals in the brain, and improving insulin sensitivity. This fundamental difference means Ozempic influences your hunger and satiety mechanisms directly, whilst Orlistat simply prevents fat absorption without affecting appetite [2].

The clinical implications are significant. Patients on Orlistat must maintain a reduced-fat diet to minimise gastrointestinal side effects, whereas those on Ozempic typically experience natural appetite suppression that makes calorie restriction easier to sustain. Both medications require prescription assessment by a UK prescriber at Cured Pharmacy, who will evaluate your BMI, medical history, and previous weight loss attempts before recommending either treatment.

Orlistat vs Ozempic: Clinical Efficacy Compared

When comparing weight loss outcomes, the clinical trial data reveals substantial differences in efficacy between these two prescription options. In pivotal trials, Orlistat 120mg three times daily produced an average weight loss of 2.9kg more than placebo over one year—approximately 5-10% total body weight reduction when combined with a reduced-calorie diet [1]. These results are consistent but modest compared to newer pharmacological interventions.

Ozempic demonstrates markedly higher efficacy in head-to-head comparisons. The STEP trials evaluating semaglutide 2.4mg weekly (the weight management dose, marketed as Wegovy rather than Ozempic) showed average weight reductions of 14.9% over 68 weeks—substantially higher than Orlistat's typical outcomes [2][3]. Even at the lower Ozempic doses prescribed for type 2 diabetes (0.5mg to 1mg weekly), patients commonly experience 5-10% body weight reduction as a secondary benefit.

It's important to note that Ozempic is licensed in the UK specifically for type 2 diabetes management, not obesity treatment alone. For weight management without diabetes, UK prescribers typically recommend Wegovy (the higher-dose semaglutide formulation) instead. At Cured Pharmacy, our clinical team assesses your eligibility for semaglutide-based treatments during your free online consultation, ensuring you receive the appropriate licensed medication for your condition.

Real-World Weight Loss Expectations

Beyond clinical trial averages, individual responses vary considerably based on baseline BMI, dietary adherence, physical activity levels, and metabolic factors. Orlistat works best for patients who can commit to a structured low-fat eating plan and who have struggled primarily with portion control rather than appetite regulation. Semaglutide-based treatments like Wegovy tend to produce more consistent results across diverse patient populations because they address the neurohormonal drivers of hunger and satiety [3].

Side Effects: What UK Patients Experience

The side effect profiles of Orlistat and Ozempic differ dramatically due to their distinct mechanisms of action. Orlistat's most common adverse effects are gastrointestinal—oily stools, faecal urgency, flatulence with discharge, and increased bowel frequency [1]. These symptoms occur because unabsorbed dietary fat passes through the digestive tract. Patients can minimise these effects by adhering strictly to a low-fat diet (less than 30% of calories from fat), but many find the gastrointestinal symptoms socially disruptive.

Ozempic and other semaglutide formulations commonly cause nausea, particularly during dose escalation, affecting approximately 20-40% of patients in clinical trials [2]. Other reported side effects include vomiting, diarrhoea, constipation, and abdominal discomfort. These gastrointestinal symptoms typically improve over 4-8 weeks as your body adjusts to the medication. UK prescribers mitigate these effects through gradual dose titration—starting at 0.25mg weekly and increasing slowly over several months.

Serious adverse events are rare with both medications but require clinical awareness. Orlistat may reduce absorption of fat-soluble vitamins (A, D, E, K), so supplementation is sometimes recommended [1]. Semaglutide carries a theoretical risk of thyroid C-cell tumours based on rodent studies, though no causal link has been established in humans; it remains contraindicated in patients with personal or family history of medullary thyroid carcinoma [2]. Your UK prescriber at Cured Pharmacy reviews these risk factors during your clinical assessment before prescribing either treatment.

Managing Side Effects in Clinical Practice

Our superintendent pharmacist Tarun Kumar advises patients starting either medication to maintain realistic expectations about side effects. With Orlistat, keeping a food diary helps identify high-fat meals that trigger symptoms. With semaglutide treatments, eating smaller meals, avoiding high-fat foods, and staying well-hydrated during the initial weeks significantly improves tolerability.

Dosing, Administration, and Convenience

Orlistat requires three times daily dosing—one 120mg capsule taken with each main meal containing fat, or up to one hour after eating. If you skip a meal or eat a fat-free meal, you omit that dose. This dosing schedule requires planning and consistency, which some patients find challenging to maintain long-term. Orlistat is taken orally, making it more convenient than injections for needle-averse patients.

Ozempic is administered as a once-weekly subcutaneous injection using a pre-filled pen device. The injection takes seconds and uses a very fine needle (32G, 4mm) injected into the abdomen, thigh, or upper arm. Most patients find the injection process straightforward after the first attempt, and the weekly schedule offers significant convenience compared to daily medications. Dose escalation follows a structured protocol: starting at 0.25mg weekly for four weeks, increasing to 0.5mg for at least four weeks, then potentially to 1mg or higher based on response and tolerability [2].

For weight management specifically, UK patients are typically prescribed Wegovy (semaglutide 2.4mg) rather than Ozempic, as Wegovy is licensed for obesity treatment. Wegovy follows a similar once-weekly injection schedule with gradual dose increases. At Cured Pharmacy, Wegovy is available with transparent upfront pricing and includes all necessary injection supplies.

Cost Considerations and UK Prescription Access

Orlistat is available both on NHS prescription (for eligible patients with BMI ≥28 with comorbidities or BMI ≥30) and privately through UK registered pharmacies. Private prescriptions for Orlistat typically cost less than GLP-1 treatments, making it the more budget-friendly option for patients who don't meet NHS criteria for newer weight loss medications.

Ozempic and Wegovy represent a higher investment but deliver substantially greater average weight loss outcomes. At Cured Pharmacy, Wegovy (semaglutide for weight management) starts from £79.00, with transparent pricing displayed before your clinical consultation [4]. This represents competitive UK pricing for genuine UK-licensed semaglutide, significantly lower than typical market rates. All semaglutide treatments require ongoing monthly prescriptions, so patients should budget for continued treatment over 6-12 months to achieve and maintain meaningful weight loss.

Both Orlistat and semaglutide-based treatments require a valid UK prescription following clinical assessment. At Cured Pharmacy, our free online consultation takes under three minutes and is reviewed by UK-registered prescribers who assess your eligibility based on NICE guidance, BMI thresholds, comorbidities, and contraindications. We never charge consultation fees, and pricing is transparent before you begin the assessment.

NHS vs Private Prescription Pathways

NHS access to weight loss medications has become increasingly restricted due to supply constraints and budget pressures. Private prescription through registered UK pharmacies like Cured Pharmacy offers faster access without NHS waiting lists, though patients bear the medication cost directly. Our clinical team follows the same prescribing guidelines as NHS services, ensuring safe and appropriate treatment selection regardless of funding route.

Which Treatment Is Right for You?

Choosing between orlistat vs ozempic uk prescription options depends on multiple clinical and practical factors. Orlistat may be more suitable if you prefer oral medication, have a BMI in the lower obesity range (30-35), can commit to a structured low-fat diet, and are seeking a more affordable option. It's particularly appropriate for patients who are needle-averse or who have contraindications to GLP-1 receptor agonists.

Semaglutide-based treatments like Wegovy are typically recommended for patients with higher BMI (≥30, or ≥27 with weight-related comorbidities), those who have not achieved adequate results with Orlistat or lifestyle modification alone, and individuals who struggle with appetite control and hunger management [3]. The once-weekly injection schedule and superior efficacy data make semaglutide the preferred option for many UK prescribers when treating obesity.

Your UK prescriber at Cured Pharmacy will assess your medical history, current medications, BMI, previous weight loss attempts, and personal preferences during your clinical consultation. Certain medical conditions contraindicate specific treatments—for example, semaglutide should not be used in pregnancy, whilst Orlistat may interfere with absorption of certain medications including levothyroxine and warfarin [1][2]. Our clinical team ensures you receive a safe, evidence-based recommendation tailored to your individual circumstances.

Many patients begin with one treatment and transition to another based on results and tolerability. This stepwise approach aligns with NICE guidance on obesity management, which recommends pharmacological intervention as an adjunct to dietary modification and increased physical activity—never as monotherapy. At Cured Pharmacy, our ongoing support includes medication reviews and dose adjustments as needed throughout your weight loss journey.

Scientific References

1. Sjöström, L., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. Cured Pharmacy. (2025). Wegovy (Semaglutide) Weight Loss Injection. Retrieved from https://curedpharmacy.com/products/wegovy-semaglutide-weight-loss-injection [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modification, and lifestyle factors.